Eduardo Bruera, Medical Doctor at MD Anderson Cancer Center, shared a post on LinkedIn about a paper he co-authored with colleagues, published in Supportive Care in Cancer:
“Tramadol provides cancer-pain relief comparable to other analgesics, with few clear advantages or disadvantages. Across 11 studies, efficacy was mostly similar, while safety varied. Due to limited dosing up to 400 mg, it may be more useful in opioid naive patients.”
Title: The use of tramadol for cancer-associated pain—a systematic review
Authors: Shivani Garlapati, Rachel Alexander, Candice Kaminski, Pavan Challa, Zsuzsanna Nemeth, Eduardo Bruera, Ronald Chow, Elizabeth Prsic
You can read the full article in Supportive Care in Cancer.
More posts featuring Eduardo Bruera.